Evidence map›Paper›PMID 42701535›Full record

ArticleCureus2026

Clinical, Immunological, and Neuroimaging Characteristics and Outcome Profile of Neurocysticercosis in Children at a Neurology Department in Antananarivo: A Retrospective Observational Study.

Julien Razafimahefa, Rivo Lova Herilanto Rakotomalala, Odilon Rahamefy, Lala A Rajaonarison, Anjanirina Rahantamalala, Alain D Tehindrazanarivelo

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julien RazafimahefaNeurology, Joseph Raseta Befelatanana University Hospital, Antananarivo, MDG.
Rivo Lova Herilanto RakotomalalaPediatrics, Tsaralalana Mother and Child University Hospital, Antananarivo, MDG.
Odilon RahamefyNeurology, Professeur Zafisaona Gabriel (PZAGA) University Hospital, Mahajanga, MDG.
Lala A RajaonarisonNeurology, Joseph Raseta Befelatanana University Hospital, Antananarivo, MDG.
Anjanirina RahantamalalaImmunology, Pasteur Institute Madagascar, Antananarivo, MDG.
Alain D TehindrazanariveloNeurology, Joseph Raseta Befelatanana University Hospital, Antananarivo, MDG.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMadagascar is an endemic area for neurocysticercosis (NCC). This study aimed to describe the clinical, immunological, and neuroimaging findings, as well as the clinical and radiological outcomes, in Malagasy children.

methodsThis retrospective, descriptive, observational cohort study was conducted from October 2013 to October 2017 in the neurology department of a hospital in Antananarivo. Pediatric cases of NCC were diagnosed using brain CT and serological tests (serum/cerebrospinal fluid). Clinical follow-up was performed for all patients, while CT/MRI follow-up was carried out only in active cases.

resultsOf the 125 patients enrolled, 30 (24%) were included in the study. The cohort consisted of 16 boys and 14 girls, with a mean age of 9.6 years (range: 2-15 years). The main symptoms were epilepsy in 26 patients (86.6%), headaches in three (10%), and dystonia in one (3.3%). Imaging revealed isolated parenchymal lesions in 11 cases (36.6%), isolated meningeal involvement in six cases (20%), and mixed involvement (parenchymal and meningeal) in 13 cases (43.3%). Analysis of outcomes showed stable epilepsy in cases with isolated parenchymal lesions or solitary calcified lesions, whereas seizure recurrence was observed in cases with mixed or multiple lesions. DISCUSSION: A high frequency of parenchymal and multiple meningeal forms was observed in Malagasy children. Early infection appears to be common, preceding the typical 5-10-year latency period required for lesion calcification. The long-term prognosis is poor in mixed forms, with a risk of drug-resistant epilepsy.

conclusionPediatric NCC requires an innovative approach to diagnosis and therapeutic management.

Indexed as

clinicalclinical and radiologicaldevelopping countryepilepsyimmunologicalmadagascarneurocysticercosisneuroimaging findingsoutcomespediatric

Identifiers

PMID42701535
PMCPMC13545700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.